Orgenesis Enters Second Phase of Collaboration with Hospital Infantil Universitario Niño Jesús in Madrid with Exclusive License to Commercialize Celyvir Solid Tumor Therapy

Author's Avatar
Mar 11, 2021
Article's Main Image

The collaboration is focused on advancing clinical development and commercialization of the oncolytic virus-based cell therapy